Agenus Inc (AGEN) – Company Profile and SWOT Analysis

Agenus Inc (AGEN) – Company Profile & SWOT Analysis, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Agenus Inc (Agenus) is a biotechnology company. It is advancing therapies targeting cancer through a pipeline of immunological agents. The company's portfolio includes several advanced platforms and programs designed to drive innovation in immuno-oncology (I-O). These consist of multiple proprietary antibody discovery platforms; antibody candidate programs such as botensilimab and balstilimab; a saponin-based vaccine adjuvant platform centered around the STIMULON cultured plant cell (CPC) QS-21 adjuvant and a pipeline of novel allogeneic invariant natural killer T (iNKT) cell therapies for treating cancer and other immune-mediated diseases. Agenus is headquartered in Lexington, Massachusetts, the US.

Scope

• Detailed information on Agenus Inc required for business and competitor intelligence needs

• A study of the major internal and external factors affecting Agenus Inc in the form of a SWOT analysis

• An in-depth view of the business model of Agenus Inc including a breakdown and examination of key business segments

• News about Agenus Inc, such as business expansion, restructuring, and contract wins

• Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

• Gain understanding of Agenus Inc and the factors that influence its strategies.

• Track strategic initiatives of the company and latest corporate news and actions.

• Assess Agenus Inc as a prospective partner, vendor or supplier.

• Support sales activities by understanding your customers' businesses better.

• Stay up to date on Agenus Incs business structure, strategy and prospects.

Note: Some sections may be missing if data is unavailable for the company.

Companies mentioned

Genor BioPharma Co Ltd

Janssen Pharmaceuticals Inc

Dynavax Technologies Corp

Amgen Inc

CSPC ZhongQi Pharmaceutical Technology Co Ltd

Boehringer Ingelheim International GmbH

Arcus Biosciences Inc

Maxinovel Pharmaceuticals

Biocad

Qilu Pharmaceutical Co Ltd

AbbVie Inc

3D Medicines Inc

Novartis AG

MacroGenics Inc

Incyte Corp

Checkpoint Therapeutics Inc

MabSpace Biosciences (Suzhou) Co Ltd

ImmuneOncia Therapeutics Inc

Table of Contents

Table of Contents

List of Tables

List of Figures

Section 1 - About the Company

Agenus Inc - Key Facts

Agenus Inc - Key Employees

Agenus Inc - Key Employee Biographies

Agenus Inc - Major Products and Services

Agenus Inc - History

Agenus Inc - Company Statement

Agenus Inc - Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Section 2 – Company Analysis

Company Overview

Agenus Inc - Business Description

Geographical Segment: Rest Of World

Performance

Geographical Segment: United States

Performance

R&D Overview

Agenus Inc - Corporate Strategy

Agenus Inc - SWOT Analysis

SWOT Analysis - Overview

Agenus Inc - Strengths

Agenus Inc - Weaknesses

Agenus Inc - Opportunities

Agenus Inc - Threats

Agenus Inc - Key Competitors

Section 3 – Company Financial Ratios

Financial Ratios - Capital Market Ratios

Financial Ratios - Annual Ratios

Performance Chart

Financial Performance

Financial Ratios - Interim Ratios

Financial Ratios - Ratio Charts

Section 4 – Company’s Lifesciences Financial Deals and Alliances

Agenus Inc, Pharmaceuticals & Healthcare, Deals By Year, 2018 to YTD 2024

Agenus Inc, Pharmaceuticals & Healthcare, Deals By Type, 2018 to YTD 2024

Agenus Inc, Recent Deals Summary

Section 5 – Company’s Recent Developments

Sep 03, 2024: Agenus to Participate in September Investor Conferences

Aug 08, 2024: Agenus Announces Appointment of Tom Harrison to Board of Directors

Jun 17, 2024: Agenus Announces Appointment of Dr. Jennifer Buell to its Board of Directors

Oct 26, 2023: Agenus to Provide Third Quarter 2023 Financial Report and Corporate Update

Jul 20, 2023: Agenus Expands Executive Leadership Team

May 09, 2023: Agenus Provides Corporate Update and First Quarter 2023 Financial Results

Mar 14, 2023: Agenus Reports Fourth Quarter and Full Year 2022 Financial Results and Outlines 2023 Objectives

Mar 11, 2023: Agenus Schedules Conference Call to Discuss the Company’s Minority Cash Holdings at SVB

Feb 28, 2023: Agenus to Provide Corporate Update and Fourth Quarter & Full Year 2022 Financial Report

Section 6 – Appendix

Methodology

Ratio Definitions

About MarketLine

Contact Us

Disclaimer

List of Tables

List of Tables

Agenus Inc, Key Facts

Agenus Inc, Key Employees

Agenus Inc, Key Employee Biographies

Agenus Inc, Major Products and Services

Agenus Inc, History

Agenus Inc, Subsidiaries

Agenus Inc, Key Competitors

Agenus Inc, Ratios based on current share price

Agenus Inc, Annual Ratios

Agenus Inc, Annual Ratios (Cont…1)

Agenus Inc, Annual Ratios (Cont…2)

Agenus Inc, Interim Ratios

Agenus Inc, Pharmaceuticals & Healthcare, Deals By Year, 2018 to YTD 2024

Agenus Inc, Pharmaceuticals & Healthcare, Deals By Type, 2018 to YTD 2024

Agenus Inc, Recent Deals Summary

Currency Codes

Capital Market Ratios

Equity Ratios

Profitability Ratios

Cost Ratios

Liquidity Ratios

Leverage Ratios

Efficiency Ratios

List of Figures

List of Figures

Agenus Inc, Performance Chart (2019 – 2023)

Agenus Inc, Ratio Charts

Agenus Inc, Pharmaceuticals & Healthcare, Deals By Year, 2018 to YTD 2024

Agenus Inc, Pharmaceuticals & Healthcare, Deals by Type, 2018 to YTD 2024

    Pricing

Quick Buy
Add to basket Enquire before buying

Discounts available for multiple purchases.

reportstore@marketline.com
+44 20 7947 2960

Saved reports